FDA and CDC announce a pause in administering the Johnson & Johnson coronavirus vaccine

During a media call with members of the Food and Drug Administration and the Centers for Disease Control and Prevention, acting FDA Commissioner Janet Woodcock said that the agencies were recommending a pause in the administration of the Johnson & Johnson vaccine for COVID-19 because of reports of blood clots.